Sana Biotechnology annual return on equity
2021
2022
2023
2024
2025
Sana Biotechnology Return on Equity (ROE) Growth & History (SANA)
Sana Biotechnology's return on equity was −118.70% for fiscal 2025.
View full Sana Biotechnology company overviewSana Biotechnology annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −118.70% | −19.54 pp |
| 2024 | 2024-12-31 | −99.17% | −27.17 pp |
| 2023 | 2023-12-31 | −72.00% | −28.10 pp |
| 2022 | 2022-12-31 | −43.90% | +187.74 pp |
| 2021 | 2021-12-31 | −231.63% | — |
Sana Biotechnology quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −46.48% | +10.09 pp |
| Q1 2026 | 2026-03-31 | −33.71% | −12.21 pp |
| Q4 2025 | 2025-12-31 | −33.03% | −14.96 pp |
| Q3 2025 | 2025-09-30 | −26.52% | −7.56 pp |
| Q2 2025 | 2025-06-30 | −56.57% | −42.50 pp |
| Q1 2025 | 2025-03-31 | −21.49% | +10.95 pp |
| Q4 2024 | 2024-12-31 | −18.07% | +8.90 pp |
| Q3 2024 | 2024-09-30 | −18.96% | −19.23 pp |
| Q2 2024 | 2024-06-30 | −14.07% | +15.04 pp |
| Q1 2024 | 2024-03-31 | −32.44% | −14.73 pp |
| Q4 2023 | 2023-12-31 | −26.97% | −11.87 pp |
| Q3 2023 | 2023-09-30 | 0.27% | +14.39 pp |
| Q2 2023 | 2023-06-30 | −29.11% | −18.30 pp |
| Q1 2023 | 2023-03-31 | −17.71% | −13.31 pp |
| Q4 2022 | 2022-12-31 | −15.10% | −0.89 pp |
| Q3 2022 | 2022-09-30 | −14.12% | −4.53 pp |
| Q2 2022 | 2022-06-30 | −10.81% | −12.90 pp |
| Q1 2022 | 2022-03-31 | −4.40% | +74.00 pp |
| Q4 2021 | 2021-12-31 | −14.21% | — |
| Q3 2021 | 2021-09-30 | −9.59% | — |
| Q2 2021 | 2021-06-30 | 2.09% | — |
| Q1 2021 | 2021-03-31 | −78.39% | — |
Sana Biotechnology return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Sana Biotechnology's return on equity increased from −231.63% to −118.70%, a change of +112.93 percentage points. The latest reported quarter, Q2 2026, shows −46.48%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sana Biotechnology source filings ↗